Maxim Pharmaceuticals other research news

MAXM received two Phase I SBIR grants

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE